查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945341

2026年全球免疫检测市场报告

Immunoassay Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，免疫检测市场经历了显着成长，预计将从2025年的373.2亿美元成长到2026年的400.7亿美元，复合年增长率（CAGR）为7.4%。过去几年的增长可归因于感染疾病和慢性病患病率的上升、临床实验室检测量的增加、基于酶联免疫吸附试验（ELISA）的诊断方法的广泛应用、药物研发活动的扩展以及对疾病早期检测需求的不断增长。

预计未来几年免疫检测市场规模将稳定成长，到2030年将达到528.3亿美元，复合年增长率（CAGR）为7.2%。预测期内的成长要素包括：对快速诊断的需求不断增长、对个人化医疗的投资不断增加、分散式检查模式的扩展、数位化检测工作流程的日益普及以及对伴随诊断的日益重视。预测期内的主要趋势包括：高灵敏度免疫检测试剂盒的广泛应用、自动化免疫检测分析仪的日益普及、照护现场检测（POC​​T）免疫检测分析的需求不断增长、多重免疫检测平台的扩展以及与数据管理软体的整合度不断提高。

预计未来几年，感染疾病和慢性病发病率的上升将推动免疫检测市场的扩张。感染疾病和慢性病包括病原体引起的疾病以及需要持续监测、诊断和治疗的长期健康问题。这些疾病发生率上升的主要原因是环境污染物暴露增加，这会损害免疫功能并增加患病风险。因此，感染疾病和慢性病的快速流行正在推动对免疫检测的需求，促使医疗机构和诊断公司采用先进的检测解决方案，以实现早期诊断、有效疾病监测和精准的临床决策。例如，根据英国政府公共卫生机构－英国 Health Security Agency）发布的数据，截至2025年6月，英格兰报告的曲状桿菌感染疾病病例数从2023年的60,055例增加到2024年的70,352例，增加了10,297例，报告率从每10万例人口104.1921.199例上升。因此，感染疾病和慢性病的日益增多推动了对基于免疫检测的诊断解决方案的需求。

为了增强竞争优势，免疫检测市场的主要企业正致力于推出先进的免疫检测分析仪。免疫检测分析仪是一种实验室系统，它透过免疫反应自动识别和测量蛋白质、荷尔蒙等生物物质。例如，2023年5月，专注于简化、自动化和创新复杂生物医学检测的美国公司贝克曼库尔特诊断（Beckman Coulter Diagnostics）推出了DxI 9000 Access免疫检测分析仪。 DxI 9000 Access免疫检测分析仪旨在满足临床检查室对速度、可靠性、可重复性、品质和扩展检测项目的需求。该系统展示了高灵敏度和临床相关检测方法的开发，有助于提高新药疗法的有效性，并有助于改善患者预后。它融合了先进的分析物处理和检测技术、精密感测器、智慧演算法和远端即时系统监控等创新技术，并且是目前唯一无需日常维护的免疫检测仪系统。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球免疫检测市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧和自主智能
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网 (IoT)、智慧基础设施和互联生态系统
  • 主要趋势
    • 高灵敏度免疫检测试剂盒的应用日益广泛
    • 自动化免疫检测装置的使用日益增多
    • 对照护现场免疫检测检测的需求日益增长
    • 扩展我们的多重免疫检测平台
    • 增强资料管理软体的集成

第五章 终端用户产业市场分析

  • 医院和诊所
  • 临床检查室
  • 研究机构和学术研究中心
  • 製药和生物技术公司
  • 血库

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球免疫检测市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球免疫检测市场规模、对比及成长率分析
  • 全球免疫检测市场表现：规模与成长，2020-2025年
  • 全球免疫检测市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 试剂和试剂盒、分析设备或仪器、软体和服务
  • 检体
  • 血液、唾液、尿液和其他检体
  • 透过使用
  • 治疗药物监测、肿瘤学、心臟病学、内分泌学、传染病检查、自体免疫疾病及其他应用
  • 最终用户
  • 研究和学术实验室、製药和生物技术公司及合约研究组织 (CRO)、医院和诊所、临床检查室
  • 按类型细分：试剂和试剂盒
  • ELISA试剂盒、快速检测套组、品管试剂及检测方法开发用试剂
  • 按类型细分：分析仪器或设备
  • 自动化分析仪、就地检验设备、微孔盘读数仪、发光仪
  • 按类型细分：软体和服务
  • 资料管理软体、分析软体、支援与维护服务、咨询服务

第十章 区域与国家分析

  • 全球免疫检测市场：依地区、表现及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球免疫检测市场：依国家、表现和预测划分，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 免疫检测市场：竞争格局及市场占有率（2024年）
  • 免疫检测市场：公司估值矩阵
  • 免疫检测市场：公司概况
    • Siemens Healthineers GmbH
    • bioMerieux
    • Abbott
    • Beckman Coulter Inc.
    • Quidel Corporation

第37章：其他领先和创新企业

  • Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年免疫检测市场：提供新机会的国家
  • 2030年免疫检测市场：充满新机会的细分市场
  • 2030年免疫检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MIMMU02_G26Q1

Immunoassay is a bioanalytical test that utilizes the binding of antibodies to antigens to detect and quantify specific chemicals, playing a crucial role in the diagnosis of diseases. Information derived from immunoassay test results can be used to establish appropriate courses of therapy. This method relies on a competitive binding reaction between a limited number of receptors on a highly specific anti-analyte antibody, labeled versions of an analyte, and a significant portion of an unlabeled sample analyte.

The main types of immunoassay products include reagents and kits, analyzers or instruments, and software and services. Reagents are substances or products that accelerate a reaction and are commonly used in various tests. Immunoassay specimens include blood, saliva, urine, and others, and the technique is applied in therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease testing, autoimmune diseases, and more. The end users of immunoassay products are diverse and include research and academic laboratories, home care settings, pharmaceutical and biotechnology companies, Contract Research Organizations (CROs), blood banks, hospitals and clinics, and clinical laboratories.

Tariffs are impacting the immunoassay market by increasing costs of imported reagents, antibodies, analyzers, electronic components, and laboratory consumables used across diagnostic and research applications. North America and Europe are most affected due to reliance on globally sourced assay materials and instrumentation, while Asia-Pacific faces cost pressures on export-oriented manufacturing of kits and analyzers. These tariffs are increasing testing costs and slowing procurement cycles for laboratories. However, they are also encouraging regional reagent manufacturing, local instrument assembly, and stronger domestic supply chains for immunoassay solutions.

The immunoassay market research report is one of a series of new reports from The Business Research Company that provides immunoassay market statistics, including immunoassay industry global market size, regional shares, competitors with a immunoassay market share, detailed immunoassay market segments, market trends and opportunities, and any further data you may need to thrive in the immunoassay industry. This immunoassay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunoassay market size has grown strongly in recent years. It will grow from $37.32 billion in 2025 to $40.07 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising prevalence of infectious and chronic diseases, increased clinical laboratory testing volumes, widespread adoption of elisa-based diagnostics, expansion of pharmaceutical research activities, growing demand for early disease detection.

The immunoassay market size is expected to see strong growth in the next few years. It will grow to $52.83 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostics, rising investments in personalized medicine, expansion of decentralized testing models, growing adoption of digital laboratory workflows, increasing focus on companion diagnostics. Major trends in the forecast period include increasing adoption of high-sensitivity immunoassay kits, rising use of automated immunoassay analyzers, growing demand for point-of-care immunoassay testing, expansion of multiplex immunoassay platforms, enhanced integration of data management software.

The rising incidence of infectious and chronic diseases is anticipated to support the expansion of the immunoassay market in the coming years. Infectious and chronic diseases encompass conditions caused by pathogenic organisms as well as long-term health disorders that require continuous monitoring, diagnosis, and treatment. The growing burden of these diseases is largely attributed to increased exposure to environmental pollutants, which compromise immune function and heighten vulnerability to illness. As a result, demand for immunoassays is increasing, as the accelerating prevalence of infectious and chronic conditions is encouraging healthcare providers and diagnostic companies to adopt advanced testing solutions that facilitate early diagnosis, effective disease surveillance, and precise clinical decision-making. For example, in June 2025, data from the UK Health Security Agency, a United Kingdom-based government public health body, indicated that reported Campylobacter cases in England rose from 60,055 in 2023 to 70,352 in 2024, representing an increase of 10,297 cases, or 17.1%, with the reporting rate climbing from 104.1 to 121.9 per 100,000 population. Consequently, the growing prevalence of infectious and chronic diseases is driving demand for immunoassay-based diagnostic solutions.

Major companies operating in the immunoassay market are focusing on the launch of advanced immunoassay analyzers to strengthen their competitive positioning. Immunoassay analyzers are laboratory systems that automate the identification and measurement of biological substances, such as proteins and hormones, through immunological reactions. For example, in May 2023, Beckman Coulter Diagnostics, a United States-based company specializing in simplifying, automating, and innovating complex biomedical testing, introduced the DxI 9000 Access Immunoassay Analyzer. The DxI 9000 Access Immunoassay Analyzer is designed to meet clinical laboratory requirements for high speed, reliability, reproducibility, quality, and expanded test menus. The system demonstrates the ability to develop highly sensitive and clinically meaningful assays, supporting the effectiveness of new pharmaceutical therapies and contributing to improved patient outcomes. It incorporates innovations such as advanced analyte processing and detection technologies, precision sensors, intelligent algorithms, and remote real-time system monitoring, and is distinguished as the only immunoassay analyzer system that requires no daily maintenance.

In January 2023, Heska Corporation, a US-based biotechnology firm, acquired MBio Diagnostics, Inc. for an undisclosed sum. This acquisition is intended to strengthen Heska Corporation's research, development, and manufacturing capabilities, primarily by incorporating LightDeck's innovative point-of-care technology. This integration will facilitate the launch of advanced diagnostic platforms, including a product for canine cancer screening. MBio Diagnostics, Inc. is a US-based company that specializes in immunoassays.

Major companies operating in the immunoassay market are Siemens Healthineers GmbH, bioMerieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

North America was the largest region in the immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the immunoassay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunoassay market includes revenues earned by entities by supplying immunoassay kits, analyzers, and reagents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunoassay Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses immunoassay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunoassay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunoassay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Reagents And Kits; Analyzers Or Instruments; Software And Services
  • 2) By Specimen: Blood; Saliva; Urine; Other Specimens
  • 3) By Application: Therapeutic Drug Monitoring; Oncology; Cardiology; Endocrinology; Infectious Disease Testing; Autoimmune Diseases; Other Applications
  • 4) By End User: Research And Academic Laboratories; Pharmaceutical And Biotechnology Companies And CROs; Hospitals And Clinics; Clinical Laboratories
  • Subsegments:
  • 1) By Reagents And Kits: ELISA Kits; Rapid Test Kits; Control Reagents; Assay Development Reagents
  • 2) By Analyzers Or Instruments: Automated Analyzers; Point-Of-Care Testing Devices; Microplate Readers; Luminometers
  • 3) By Software And Services: Data Management Software; Analytical Software; Support And Maintenance Services; Consulting Services
  • Companies Mentioned: Siemens Healthineers GmbH; bioMerieux; Abbott; Beckman Coulter Inc.; Quidel Corporation; Ortho Clinical Diagnostics; Sysmex Corporation; Bio-Rad Laboratories Inc.; Becton Dickinson and Company; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Merck KGaA; Agilent Technologies Inc.; PerkinElmer Inc; WAK-Chemie Medical GmbH; J Mitra & Co Pvt Ltd; Kamiya Biomedical Company; Tosoh Corporation; Gyros Protein Technologies AB; BioCheck Inc.; Bio-Techn; DiaSorin S.p.A; Meso Scale Diagnostics LLC; QIAGE; Randox Laboratories Ltd.; Shenzhen Mindray Bio-Medical Electronics Co Ltd; Danaher Corporation; Hologic Inc.; Tecan Trading AG; Eurofins Scientific; Abcam plc; Enzo Biochem Inc.; Luminex Corporation; Quanterix Corporation; Roche Diagnostics; ZEUS Scientific Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Immunoassay Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Immunoassay Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Immunoassay Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Immunoassay Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics And Precision Medicine
    • 4.1.2 Artificial Intelligence And Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.4 Industry 4.0 And Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of High-Sensitivity Immunoassay Kits
    • 4.2.2 Rising Use Of Automated Immunoassay Analyzers
    • 4.2.3 Growing Demand For Point-Of-Care Immunoassay Testing
    • 4.2.4 Expansion Of Multiplex Immunoassay Platforms
    • 4.2.5 Enhanced Integration Of Data Management Software

5. Immunoassay Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Clinical Laboratories
  • 5.3 Research And Academic Laboratories
  • 5.4 Pharmaceutical And Biotechnology Companies
  • 5.5 Blood Banks

6. Immunoassay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Immunoassay Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Immunoassay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Immunoassay Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Immunoassay Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Immunoassay Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Immunoassay Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Immunoassay Market Segmentation

  • 9.1. Global Immunoassay Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagents And Kits, Analyzers Or Instruments, Software And Services
  • 9.2. Global Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood, Saliva, Urine, Other Specimens
  • 9.3. Global Immunoassay Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications
  • 9.4. Global Immunoassay Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Research And Academic Laboratories, Pharmaceutical And Biotechnology Companies And CROs, Hospitals And Clinics, Clinical Laboratories
  • 9.5. Global Immunoassay Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents
  • 9.6. Global Immunoassay Market, Sub-Segmentation Of Analyzers Or Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers
  • 9.7. Global Immunoassay Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

10. Immunoassay Market Regional And Country Analysis

  • 10.1. Global Immunoassay Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Immunoassay Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Immunoassay Market

  • 11.1. Asia-Pacific Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Immunoassay Market

  • 12.1. China Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Immunoassay Market

  • 13.1. India Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Immunoassay Market

  • 14.1. Japan Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Immunoassay Market

  • 15.1. Australia Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Immunoassay Market

  • 16.1. Indonesia Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Immunoassay Market

  • 17.1. South Korea Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Immunoassay Market

  • 18.1. Taiwan Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Immunoassay Market

  • 19.1. South East Asia Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Immunoassay Market

  • 20.1. Western Europe Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Immunoassay Market

  • 21.1. UK Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Immunoassay Market

  • 22.1. Germany Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Immunoassay Market

  • 23.1. France Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Immunoassay Market

  • 24.1. Italy Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Immunoassay Market

  • 25.1. Spain Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Immunoassay Market

  • 26.1. Eastern Europe Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Immunoassay Market

  • 27.1. Russia Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Immunoassay Market

  • 28.1. North America Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Immunoassay Market

  • 29.1. USA Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Immunoassay Market

  • 30.1. Canada Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Immunoassay Market

  • 31.1. South America Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Immunoassay Market

  • 32.1. Brazil Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Immunoassay Market

  • 33.1. Middle East Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Immunoassay Market

  • 34.1. Africa Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Immunoassay Market Regulatory and Investment Landscape

36. Immunoassay Market Competitive Landscape And Company Profiles

  • 36.1. Immunoassay Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Immunoassay Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Immunoassay Market Company Profiles
    • 36.3.1. Siemens Healthineers GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. bioMerieux Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Beckman Coulter Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Immunoassay Market Other Major And Innovative Companies

  • Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc.

38. Global Immunoassay Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Immunoassay Market

40. Immunoassay Market High Potential Countries, Segments and Strategies

  • 40.1 Immunoassay Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Immunoassay Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Immunoassay Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer